LOGO
LOGO

Biotech Daily Dose

ISpecimen Prices $2.5Mln Private Placement To Support Marketplace Expansion

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

iSpecimen Inc. (ISPC) Friday announced that it has priced a $2.5 million private placement with accredited investors. The financing involves the issuance of 488,281 shares of common stock at $5.12 per share, with certain investors receiving pre-funded warrants at $5.1199 per warrant in lieu of shares to manage ownership thresholds.

The company stated that net proceeds will be used for working capital, including up to $900,000 earmarked for marketing expenses. The offering is expected to close today, May 11, 2026, subject to customary conditions.

Under Nasdaq rules, the total number of shares issuable in the transaction is capped at 19.99% of outstanding stock until shareholder approval is obtained. iSpecimen has agreed to file a proxy statement within 30 days and hold a shareholder meeting within 90 days to seek approval.

E.F. Hutton & Co. is acting as exclusive placement agent, with Sichenzia Ross Ference Carmel LLP serving as company counsel and Zarif Law Group P.C. representing the placement agent.

The company recently implemented a 1-for-40 reverse stock split on April 27, 2026.

ISPC closed Friday's trading (May 8, 2026) at $5.12, down 3.21%. During overnight trading, the stock is at $5.33, up 4.10%.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - May 04 – May 08, 2026

May 08, 2026 15:50 ET
Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.

Latest Updates on COVID-19